Noxafil

Active Ingredient(s): Posaconazole
FDA Approved: * September 15, 2006
Pharm Company: * SCHERING
Category: Antifungal

Posaconazole, sold under the brand names Noxafil and Posanol is a triazole antifungal medication.[2][3] It was approved for medical use in the United States in September 2006,[4] and is available as a generic medication.[5] Contents 1 Medical uses 2 Pharmacology 2.1 Pharmacodynamics 2.1.1 Microbiology 2.2 Pharmacokinetics 3 References 4 External links Medical uses Posaconazole is used to treat invasive Aspergillus an... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Noxafil 100 mg/1 Oral Tablet, Coated

NDC: 0085-4324

Labeler:

Merck Sharp & Dohme Corp.

Noxafil 40 mg/ml Oral Suspension

NDC: 0085-1328

Labeler:

Merck Sharp & Dohme Corp.

Noxafil 300 mg Oral Powder, for Suspension

NDC: 0085-2224

Labeler:

Merck Sharp & Dohme Corp.

Noxafil 18 mg/ml Intravenous Solution

NDC: 0085-4331

Labeler:

Merck Sharp & Dohme Corp.